consider the preferences and familiarity of the patient population with these technologies prior to implementation of a novel communication method. Elderly patients usually prefer to receive personal assistance from a human operator, whereas younger patients typically feel more comfortable with a ''robocall,'' texting, or e-mail.
In this issue of Digestive Diseases and Sciences, Thomson et al. [4] describe and validate the use of an automated telephone monitoring system with interactive voice response (IVR) in the prediction of readmission for patients with cirrhosis. Despite patient dissatisfaction with automated telephone systems cited by other studies, this pilot study reported a high level of compliance, with 70 % of patients completing over 80 % of their IVR assessments, particularly among patients with cirrhosis, who are frequently noncompliant. Furthermore, the responses provided by this population enabled the authors to successfully predict which subjects would be hospitalized, while increasing the value of face-to-face encounters with the treating physician(s) through the provision of additional information [4] .
IVR monitoring has the potential to improve the efficiency and effectiveness of hepatology care by predicting which patients are stable enough to require less frequent communication versus patients who demand additional interventions. Nevertheless, since responses collected from automated telephone systems are largely dichotomous (yes/ no) or ordinal (limited to a Likert scale rating of how the patient is feeling), these types of data are not conducive to immediate intervention. As the authors note, although scheduled calls with a member of the patient's care team between office visits could provide more detailed data for informing management decisions, these calls are resource intensive.
We have some experience with a pilot study utilizing a liver care coordinator (LCC) as a comprehensive point-of-contact between patients with cirrhosis and their treating hepatologist. Patients with advanced liver disease called in daily or weekly to report their basic data such as blood pressure, weight, and mental status in order to inform medical management decisions or to recommend additional office visits. Furthermore, the LCC acted as a patient ''navigator,'' connecting them to their PCP, other specialists, or to care team members, assisting with insurance prior to authorizations for medications and screenings, and connecting patients to other resources, as needed. The LCC pilot study, which had a lower initial cost than the IVR system (\$60,000), collected actionable patient data (beyond dichotomous/ordinal responses) and provided a possibility for a rapid intervention ( Table 1) . As Thomson et al. note, care management interventions such as the LCC model, which involve human intervention, do not benefit from the economies of scale, with expenses increasing over time and with expansion of the patient pool.
As such, the IVR system represents an excellent first step toward improving patient-physician communication.
Increasing the amount of information available to hepatologists between face-to-face office visits provides the opportunity for improving care and for reducing preventable and costly rehospitalizations. In the future, the prognostic data collected by the IVR system could be used to formulate standardized interventions. 
